Infektionskrankheit

The Infectious Disease theme encompasses companies developing prevention, detection, and treatment solutions for viral, bacterial, and emerging pathogens. Core tracks include vaccines and platform technologies (mRNA, viral vectors), anti-infective therapeutics and monoclonal antibodies, rapid and molecular diagnostics, genomic surveillance and biosecurity, hospital infection control and sterilization, and public-health data analytics and distribution, spanning the value chain from research and clinical trials to manufacturing, point-of-care testing, and outbreak response.The sector's total market cap is 2345.21 billion USD, with a 24h change of +0.60%. Among 16 constituents, 14 are up (87.50%) and 2 are down (12.50%). The top gainer is Moderna, Inc. (MRNA), with a 24h increase of +2.88%.Firm breadth, tight leadership; favor large caps. Short-term trade momentum; add on trial and approval catalysts.